| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 21, 2005
Revised on June 12, 2006
Accepted on July 11, 2006
From Cardiovascular Division (Y.H., Y.-S.C., Z.L., N.B., D.R., P.M.K.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; Department of Cardiology (E.B., W.T.P.), Children’s Hospital Boston, Boston, Mass.
* To whom correspondence should be addressed. E-mail: pkang{at}bidmc.harvard.edu.
Caspase-9 is a critical regulator of mitochondria-mediated apoptosis. We found that adult cardiac myocytes, but not nonmyocytes, have high caspase-9 expression, and exhibit relative resistance to caspase-9-induced cell death. Thus, we hypothesized that cardiac myocytes possess factors that resist apoptosis. Through a yeast two-hybrid screening of adult human heart cDNA library, we identified HS-1 associated protein-1 (HAX-1), a 35-kD BH-domain containing protein localized to the mitochondria as one of the molecules that interacts with caspase-9. Recombinant HAX-1 protein inhibited caspase-9 processing in a dose-dependent manner in a cell-free caspase activation assay. Overexpression of HAX-1 in adult cardiac myocytes conferred 30% protection from apoptosis as compared with the control. Suppression of HAX-1 expression using siRNA-HAX-1 resulted in significant cell death in adult cardiac myocytes, suggesting the importance of HAX-1 in cardiac myocyte resistance to apoptotic stimulation. On apoptotic stimulation, some caspase-9 translocated to the mitochondria and co-localized with HAX-1, confirming the spatial proximity of caspase-9 and HAX-1. In summary, HAX-1 is a newly identified anti-apoptotic factor and its mechanism of action is through caspase-9 inhibition.
Related Article:
This article has been cited by other articles:
![]() |
S. Jitkaew, A. Trebinska, E. Grzybowska, G. Carlsson, A. Nordstrom, J. Lehtio, A.-S. Frojmark, N. Dahl, and B. Fadeel N{alpha}-Tosyl-L-phenylalanine Chloromethyl Ketone Induces Caspase-dependent Apoptosis in Transformed Human B Cell Lines with Transcriptional Down-regulation of Anti-apoptotic HS1-associated Protein X-1 J. Biol. Chem., October 9, 2009; 284(41): 27827 - 27837. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banerjee, K. Saito, K. Meyer, S. Banerjee, M. Ait-Goughoulte, R. B. Ray, and R. Ray Hepatitis C Virus Core Protein and Cellular Protein HAX-1 Promote 5-Fluorouracil-Mediated Hepatocyte Growth Inhibition J. Virol., October 1, 2009; 83(19): 9663 - 9671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choudhury, S. Bae, S. R. Kumar, Q. Ke, B. Yalamarti, J. H. Choi, L. A. Kirshenbaum, and P. M. Kang Role of AIF in cardiac apoptosis in hypertrophic cardiomyocytes from Dahl salt-sensitive rats Cardiovasc Res, August 14, 2009; (2009) cvp261v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Sue, C.-F. Cheng, C.-C. Chang, Y. Chou, C.-H. Chen, and S.-H. Juan Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells Nephrol. Dial. Transplant., March 1, 2009; 24(3): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rigor, N. Bodyak, S. Bae, J. H. Choi, L. Zhang, D. Ter-Ovanesyan, Z. He, J. R. McMullen, T. Shioi, S. Izumo, et al. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase C{beta}2 in the regulation of physiologic developmental hypertrophy and heart function Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H566 - H572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vafiadaki, D. A. Arvanitis, S. N. Pagakis, V. Papalouka, D. Sanoudou, A. Kontrogianni-Konstantopoulos, and E. G. Kranias The Anti-apoptotic Protein HAX-1 Interacts with SERCA2 and Regulates Its Protein Levels to Promote Cell Survival Mol. Biol. Cell, January 1, 2009; 20(1): 306 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsubara, K. Imai, S. Okada, M. Miki, N. Ishikawa, M. Tsumura, T. Kato, O. Ohara, S. Nonoyama, and M. Kobayashi Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency Haematologica, December 1, 2007; 92(12): e123 - e125. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xu, Y. Lu, Z. Pan, W. Chu, X. Luo, H. Lin, J. Xiao, H. Shan, Z. Wang, and B. Yang The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes J. Cell Sci., September 1, 2007; 120(17): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shaw and L. A. Kirshenbaum HAX-1 Represses Postmitochondrial Caspase-9 Activation and Cell Death During Hypoxia-Reoxygenation Circ. Res., August 18, 2006; 99(4): 336 - 338. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |